Cover Image

Complete pathological remission and tertiary lymphoid structures are associated with the efficacy of resectable NSCLC receiving neoadjuvant chemoimmunotherapy: A double-center retrospective study

ABSTRACTThis study aimed to investigate the relationship between complete pathological remission (PCR), tertiary lymphoid structure (TLS) maturation and expression and clinical outcomes of patients with resectable non-small cell lung cancer (NSCLC) receiving neoadjuvant chemoimmunotherapy. Totally 8...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ying Liu (Author), Lei Xiong (Author), Yue Chen (Author), Ruoxue Cai (Author), Xinyu Xu (Author), Tian Wang (Author), Yiyu Guo (Author), Luxi Ruan (Author), Ying Fang (Author), Quanan Zhang (Author), Bo Shen (Author), Jinjun Ye (Author), Guoren Zhou (Author)
Format:	Book
Published:	Taylor & Francis Group, 2023-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Symptomatic Follicular Lymphoma: Complete Remission After Chemoimmunotherapy with Bendamustine-Rituximab
by: Wulyo Rajabto, et al.
Published: (2024)

Neoadjuvant chemoimmunotherapy for small cell carcinoma of the esophagus: Clinical efficacy and biomarker exploration
by: Junhan Wu, et al.
Published: (2024)

EGFR Inhibitors for Neoadjuvant and Adjuvant Therapy of NSCLC
by: Fabio Villa
Published: (2015)

Disease-free remission of metastatic adrenocortical carcinoma following en bloc tumor resection and neoadjuvant chemotherapy for suspected adrenohepatic infiltration
by: Daniel Pasquale Cinelli, et al.
Published: (2021)

Correlation of Endoscopic Findings of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma with Recurrence after Complete Remission
by: Chang Min Lee, et al.
Published: (2017)

Sustained remission of recalcitrant cutaneous lymphoid hyperplasia after thalidomide treatment
by: Stephen P. Erickson, BS, et al.
Published: (2018)

Advances in Lipid-Based Nanoparticles for Cancer Chemoimmunotherapy
by: Tianqi Wang, et al.
Published: (2021)

Tertiary lymphoid structures favor outcome in resected esophageal squamous cell carcinoma
by: Rutao Li, et al.
Published: (2022)

Possibility of Endoscopic Resection in Localized Gastric Mucosa-associated Lymphoid Tissue Lymphoma
by: Sun Hyung Kang
Published: (2023)

Case report: Leptomeningeal metastasis of advanced nasopharyngeal carcinoma treated with chemoimmunotherapy
by: Mengting Shi, et al.
Published: (2023)

An Unexpected Complete Remission of Advanced Intestinal-Type Vulvar Adenocarcinoma after Neoadjuvant Chemotherapy: A Case Report and a Literature Review
by: Angela Musella, et al.
Published: (2013)

Neoadjuvant targeted therapy for resectable EGFR-mutant non-small cell lung cancer: Current status and future considerations
by: Wenliang Liu, et al.
Published: (2022)

Macrophage-camouflaged epigenetic nanoinducers enhance chemoimmunotherapy in triple negative breast cancer
by: Tong Gao, et al.
Published: (2023)

A Novel Predictor of Pathologic Complete Response for Neoadjuvant Immunochemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
by: Yang Y, et al.
Published: (2023)

Pathological complete remission of a locally advanced gastric cancer by neoadjuvant therapy "sandwich" regimen as SOXAP+ fluorescence laparoscopic surgery +SOXAP: Case report
by: Yanling Ma, et al.
Published: (2022)

Successful Endoscopic Resection of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Unresponsive to Eradication Therapy
by: Jeongmin Choi
Published: (2022)

Successful Endoscopic Resection of Residual Colonic Mucosa-Associated Lymphoid Tissue Lymphoma after Polypectomy
by: Jeongmin Choi
Published: (2021)

Dual-responsive nanosystem based on TGF-β blockade and immunogenic chemotherapy for effective chemoimmunotherapy
by: Xiaoxian Huang, et al.
Published: (2022)

Chemoimmunotherapy Administration Protocol Design for the Treatment of Leukemia through Mathematical Modeling and In Silico Experimentation
by: Paul A. Valle, et al.
Published: (2022)

Role of Neoadjuvant Immune Checkpoint Inhibitors in Resectable Non-Small Cell Lung Cancer
by: Ivy Riano, et al.
Published: (2023)

Comparative Effectiveness of Neoadjuvant Treatments for Resectable Gastroesophageal Cancer: A Network Meta-Analysis
by: Zhaolun Cai, et al.
Published: (2018)

Case Report: Pathological Complete Response to Neoadjuvant Alectinib in a Patient With Resectable ALK-Positive Non-Small Cell Lung Cancer
by: Yan Hu, et al.
Published: (2022)

Remission of secondary membranous nephropathy in a patient with Kimura disease after surgical resection
by: Sunhwa Lee, et al.
Published: (2014)

Osimertinib as Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: A Case Series
by: Yan Hu, et al.
Published: (2022)

Evidence for the evolving role of neoadjuvant and perioperative immunotherapy in resectable non-small cell lung cancer
by: Thomas Hansen, et al.
Published: (2024)

Complete Remission in Childhood-Onset Epilepsy
by: J Gordon Millichap
Published: (2011)

Stromal Lymphoid Response Status in Micropapillary Urothelial Carcinomas Diagnosed in Bladder Transurethral Resections and its Comparison with Conventional Urothelial Carcinomas
by: Ezgi HACIHASANOĞLU, et al.
Published: (2021)

Emerging precision neoadjuvant systemic therapy for patients with resectable non-small cell lung cancer: current status and perspectives
by: Luis A. Godoy, et al.
Published: (2023)

Advancing neoadjuvant therapies in resectable non-small cell lung cancer: implications for novel treatment strategies and biomarker discovery
by: Hyein Jeon, et al.
Published: (2024)

A pH/ROS dual-responsive system for effective chemoimmunotherapy against melanoma via remodeling tumor immune microenvironment
by: Leilei Wang, et al.
Published: (2024)

Morphological Features of Lymphoid Structures of Nasooropharynx in Children with Hyperplasia of Pharyngeal Lymphoid Ring
by: L.S. Ovcharenko, et al.
Published: (2015)

Prognostic impact of muscle mass loss in elderly patients with oesophageal cancer receiving neoadjuvant chemoradiation therapy
by: Jeong Yun Jang, et al.
Published: (2024)

Is it possible that we can increase the lymph node number in cases with rectum tumor receiving neoadjuvant therapy?
by: Selma Şengiz Erhan, et al.
Published: (2023)

Neoadjuvant chemotherapy increases the 5-year overall survival of patients with resectable cervical cancer: A systematic review and meta-analysis
by: Yunbao Xu, et al.
Published: (2021)

Predictive value of tumor-infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancers
by: Miao Ruan, et al.
Published: (2018)

Pathologic Complete Response Prediction to Neoadjuvant Immunotherapy Combined with Chemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: Real-World Evidence from Integrative Inflammatory and Nutritional Scores
by: Feng J, et al.
Published: (2022)

TCR Coexpression Signature Predicts Immunotherapy Resistance in NSCLC
by: Yuntao Wang, et al.
Published: (2022)

Early complete remission of osteoid osteoma with conservative medical management
by: Masahiro Yokouchi, et al.
Published: (2014)

Front-line chemoimmunotherapy for treating epithelial ovarian cancer: Part II promising results of phase 2 study of paclitaxel-carboplatin-oregovomab regimen
by: Szu-Ting Yang, et al.
Published: (2024)

Post-neoadjuvant chemoradiotherapy tumor resectability following induction chemotherapy in locally advanced proximal gastric and adenocarcinoma of the esophagogastric junction: A clinical trial
by: Seyed Amir Aledavood, et al.
Published: (2021)